Royal Bank Of Canada Issues Positive Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its target price increased by analysts at Royal Bank Of Canada from $482.00 to $525.00 in a note issued to investors on Friday,MarketScreener reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price would suggest a potential upside of 12.63% from the company’s current price.

Several other research firms also recently weighed in on HCA. Cowen reissued a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Stephens raised their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday, October 27th. Mizuho raised their target price on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Robert W. Baird boosted their target price on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Stock Down 1.2%

Shares of NYSE HCA opened at $466.13 on Friday. The firm’s 50-day simple moving average is $468.96 and its 200 day simple moving average is $416.17. HCA Healthcare has a fifty-two week low of $289.98 and a fifty-two week high of $520.00. The stock has a market cap of $106.37 billion, a P/E ratio of 18.04, a P/E/G ratio of 1.39 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts anticipate that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company’s stock.

Institutional Trading of HCA Healthcare

Hedge funds have recently modified their holdings of the company. Palisade Asset Management LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at $26,000. Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Clearstead Trust LLC increased its position in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the period. Ameriflex Group Inc. acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth $27,000. Finally, Saudi Central Bank acquired a new position in HCA Healthcare during the first quarter valued at approximately $26,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.